Nebivolol

Primary Use

Nebivolol is primarily used to manage high blood pressure, also known as hypertension. It belongs to a class of drugs called beta-blockers.

Health Benefits

Lowering high blood pressure helps reduce the risk of serious health complications, such as:

• Heart attacks
• Strokes
• Kidney problems

Nebivolol may be prescribed as a single therapy or used alongside other medications to achieve blood pressure goals. It is important to continue taking the medication even if you feel well, as high blood pressure often has no visible symptoms.

How Nebivolol Works

Nebivolol belongs to a group of medicines known as beta-blockers. It works by blocking the action of certain natural substances in the body, such as epinephrine, on the heart and blood vessels.

This medication affects the body in two primary ways:

• Heart Rate Reduction: It slows down the heart rate and decreases the force with which the heart muscle contracts. This reduces the workload on the heart.
• Vasodilation: Unlike many older beta-blockers, nebivolol helps the walls of the blood vessels relax and widen. It does this by increasing the availability of nitric oxide, a substance that signals the blood vessels to expand.

By slowing the heart and widening the blood vessels, nebivolol helps lower blood pressure, making it easier for the heart to pump blood throughout the body.

Common Side Effects

Many people using nebivolol do not experience serious side effects. Common symptoms may include:

• Headache
• Dizziness
• Fatigue or unusual tiredness
• Diarrhea
• Nausea or stomach pain
• Trouble sleeping
• Numbness or tingling sensations in the hands or feet

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Slow or irregular heartbeat
• Fainting or severe lightheadedness
• New or worsening shortness of breath
• Swelling of the hands, ankles, or feet
• Sudden, unexplained weight gain
• Chest pain
• Coldness, numbness, or a blue color in the fingers or toes
• Signs of a severe allergic reaction, such as a rash, hives, or swelling of the face, lips, or throat

Abrupt Discontinuation

Stopping nebivolol suddenly can lead to serious heart-related problems, including worsening chest pain (angina) or a heart attack. If the medication must be discontinued, the dose is typically reduced gradually over one to two weeks under medical supervision.

Heart and Circulatory Conditions

Nebivolol is not recommended for individuals with certain heart conditions, including:

• Severe bradycardia (very slow heart rate).
• Heart block greater than first degree.
• Cardiogenic shock.
• Decompensated heart failure.
• Sick sinus syndrome, unless a permanent pacemaker is in place.

The medication may also worsen symptoms of peripheral vascular disease by reducing blood circulation to the hands and feet.

Respiratory Issues

Patients with bronchospastic diseases, such as asthma or chronic obstructive pulmonary disease (COPD), are generally advised to avoid beta-blockers. While nebivolol is more selective than some other medications in its class, it may still cause breathing difficulties, particularly at higher doses.

Diabetes and Hypoglycemia

Nebivolol can mask certain symptoms of low blood sugar (hypoglycemia), such as a rapid heartbeat. This may make it more difficult for patients with diabetes to recognize when their blood sugar is low.

Thyroid Function

This medication may hide the signs of an overactive thyroid (hyperthyroidism), such as a fast pulse. Abruptly stopping nebivolol in patients with hyperthyroidism could potentially trigger a serious condition known as a thyroid storm.

Liver and Kidney Impairment

Nebivolol is not recommended for individuals with severe liver impairment. For those with moderate liver disease or severe kidney disease, a lower starting dose is usually necessary.

Metabolism and Genetic Factors

The body uses a specific enzyme (CYP2D6) to break down nebivolol. Some individuals, known as poor metabolizers, process the drug more slowly, which can lead to higher levels of the medication in the blood and an increased risk of side effects.

Surgery and Anesthesia

It is important for surgical teams to be aware if a patient is taking nebivolol, as the medication can interact with certain general anesthetics that affect heart function during surgery.

Pregnancy

Nebivolol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Beta-blockers as a class may reduce blood flow to the placenta, which can lead to several complications, including:

• Intrauterine growth retardation
• Premature delivery
• Fetal death

Newborns exposed to nebivolol late in pregnancy may also be at risk for certain side effects after birth, such as a slow heart rate (bradycardia) or low blood sugar (hypoglycemia). Individuals who are pregnant or planning to become pregnant should discuss treatment options and potential risks with their healthcare provider.

Breastfeeding

It is currently unknown whether nebivolol is excreted in human breast milk. However, animal studies have shown that the drug is present in the milk of lactating rats. Because many drugs are excreted in human milk and there is a potential for serious adverse reactions in nursing infants, a decision must be made whether to stop breastfeeding or stop taking the medication. Patients should consult with their healthcare provider to weigh the importance of the drug to the mother against the potential risks to the nursing child.

Available Forms

Nebivolol is currently available in the following form:

• Oral Tablet: This medication is taken by mouth, typically once per day.

The tablets are produced in various strengths to allow for precise dosing as directed by a healthcare provider. Your doctor will determine the appropriate strength based on your medical condition and how you respond to the medication.

FDA Approval and Indications

Nebivolol is approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension. It is indicated for use as a standalone treatment or in combination with other medications designed to lower blood pressure.

Regulatory Status

Nebivolol is a prescription-only medication and is not classified as a controlled substance. There is currently no Risk Evaluation and Mitigation Strategy (REMS) required for its distribution or use.

Safety Communications

The FDA-approved labeling contains specific warnings regarding the abrupt discontinuation of therapy. While nebivolol does not carry a boxed warning, patients are cautioned that stopping the medication suddenly can lead to a worsening of heart conditions, such as chest pain or heart attack. Healthcare providers typically manage the discontinuation process by gradually tapering the dose over one to two weeks.

Pharmacogenomic Labeling

The FDA includes nebivolol in its table of pharmacogenomic biomarkers because the medication is primarily metabolized by the CYP2D6 enzyme. Genetic variations in how an individual processes this enzyme can affect how quickly the drug is cleared from the body. In patients who are poor metabolizers, the concentration of the drug in the blood may be significantly higher than in extensive metabolizers, though the clinical impact on blood pressure reduction is generally modest.

Generic vs. Brand Name

Nebivolol is available as a generic medication. Generic versions of beta-blockers are generally less expensive than brand-name versions. Choosing the generic form is a common way to reduce the overall cost of treatment.

Insurance and Medicare Coverage

Most insurance plans and Medicare Part D cover the generic version of nebivolol. The out-of-pocket cost will depend on your plan's formulary, deductible, and copayment structure. Brand-name versions may require prior authorization or a higher copay.

Factors Influencing Price

Several factors can affect the final price of nebivolol at the pharmacy:

• Pharmacy Choice: Prices can vary between different retail pharmacies and mail-order services.
• Prescription Quantity: Purchasing a 90-day supply may offer a different per-dose cost compared to a 30-day supply.
• Dosage Strength: The cost may vary depending on the specific strength of the tablets prescribed by your healthcare provider.